PL EN
REVIEW PAPER
Capsular Glaucoma and Other Ophthalmic Complications of Pseudoexfoliation Syndrome
 
More details
Hide details
1
Department of Diagnostics and Microsurgery of Glaucoma, Medical University of Lublin, Poland
 
 
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article
 
 
Submission date: 2025-09-30
 
 
Acceptance date: 2025-10-09
 
 
Publication date: 2025-11-06
 
 
Corresponding author
Piotr Witold Stępień   

Klinika Diagnostyki i Mikrochirurgii Jaskry, Uniwersytet Medyczny w Lublinie, Poland
 
 
Ophthalmology 2025;28(2):40-45
 
KEYWORDS
TOPICS
ABSTRACT
Pseudoexfoliation syndrome is an age-related disorder of the extracellular matrix, characterized by the deposition of pathological fibrillar material in the structures of the anterior segment of the eye and in extraocular tissues. The accumulation of pseudoexfoliative material leads to damage and impaired function of tissues such as the lens zonules, the iris, or the drainage angle. Pseudoexfoliation syndrome is a disease entity with a multifactorial pathogenesis, involving both genetic and environmental factors, among which LOXL1 gene polymorphisms, exposure to UV radiation, and oxidative stress play a particularly significant role. Pseudoexfoliation syndrome is the most common cause of secondary open-angle glaucoma, which is characterized by a more severe course and a poorer prognosis compared to primary open-angle glaucoma. Secondary open-angle glaucoma is associated with higher intraocular pressure values and its greater diurnal fluctuations. The treatment of secondary open-angle glaucoma involves the same methods as those used for primary open-angle glaucoma; however, the specific features of glaucoma in this patient group must be taken into account. Pseudoexfoliation syndrome also predisposes to cataract formation and intra- and postoperative complications, such as poor pupillary dilation, corneal decompensation, or lens dislocation, as well as systemic diseases. Due to its prevalence and clinical significance, Pseudoexfoliation syndrome represents a major diagnostic and therapeutic challenge in contemporary ophthalmology.
REFERENCES (32)
1.
Ritch R, Schlötzer-Schrehardt U: Exfoliation syndrome. Surv Ophthalmol. 2001; 45: 265–315.
 
2.
Grzybowski A, Kanclerz P, Ritch R: The History of Exfoliation Syndrome. Asia-Pacific Journal of Ophthalmology. 2019; 8(1): 55–61.
 
3.
Terminology and Guidelines for Glaucoma (5th edition) European Glaucoma Society (EGS).
 
4.
Arnarsson A, Damji KF, Sverrisson T, et al.: Pseudoexfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables. Acta Ophthalmol Scand. 2007; 85(8): 822–827.
 
5.
Konstas AGP, Ringvold A: Epidemiology of Exfoliation Syndrome. Journal of Glaucoma. 2018; 2: 4–11.
 
6.
Anastasopoulos E, Founti P, Topouzis F: Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases. Curr Opin Ophthalmol. 2015; 26(2): 82–89.
 
7.
Kivelä TT: Histopathology of Exfoliation Syndrome. Journal of Glaucoma. 2018; 27: 38–43.
 
8.
Schlötzer-Schrehardt U: Genetics and Genomics of Pseudoexfoliation Syndrome/Glaucoma. Middle East African Journal of Ophthalmology. 2011; 18(1): 30–36.
 
9.
Krumbiegel M, Pasutto F, Schlötzer-Schrehardt U, et al.: Genome-wide association study with DNA pooling identifies variants at CNTNAP2 associated with pseudoexfoliation syndrome. Eur J Hum Genet. 2011; 19: 186–193.
 
10.
Li Z, Wang Z, Lee MC, Zenkel M et al.: [Genetics of Exfoliation Syndrome Partnership] Association of Rare CYP39A1 Variants With Exfoliation Syndrome Involving the Anterior Chamber of the Eye. JAMA. 2021; 325(8): 753–764.
 
11.
Aung T, Ozaki M, Mizoguchi T, et al.: A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome. Nat Genet. 2015; 47(4): 387–392.
 
12.
Czop M, Gasińska K, Kosior-Jarecka E, et al.: Twenty Novel MicroRNAs in the Aqueous Humor of Pseudoexfoliation Glaucoma Patients. Cells. 2023; 12: 737.
 
13.
Gasińska K, Czop M, Kosior-Jarecka E, et al.: Small Nucleolar RNAs in Pseudoexfoliation Glaucoma. Cells. 2022; 11(17): 2738.
 
14.
Aung T, Ozaki M, Lee MC, et al.: Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci. Nat Genet. 2017; 49(7): 993–1004.
 
15.
Pasquale LR, Jiwani AZ, Zehavi-Dorin T, et al.: Solar exposure and residential geographic history in relation to exfoliation syndrome in the United States and Israel. JAMA Ophthalmol. 2014; 132(12): 1439–1445.
 
16.
Mastronikolis S, Pagkalou M, Plotas P, et al.: Emerging roles of oxidative stress in the pathogenesis of pseudoexfoliation syndrome. Exp Ther Med. 2022; 24: 602.
 
17.
Yüksel N, Yılmaz Tuğan B: Pseudoexfoliation Glaucoma: Clinical Presentation and Therapeutic Options. Turk J Ophthalmol. 2023; 53(4): 247– –256.
 
18.
Sampaolesi R, Zarate J, Croxato O: The chamber angle in exfoliation syndrome. Clinical and pathological findings. Acta Ophthalmol Suppl. 1988;184: 48–53.
 
19.
Yarangümeli A, Davutluoglu B, Köz OG, et al.: Glaucomatous damage in normotensive fellow eyes of patients with unilateral hypertensive pseudoexfoliation glaucoma: normotensive pseudoexfoliation glaucoma? Clin Exp Ophthalmol. 2006; 34(1): 15–19.
 
20.
Rao A, Padhy D, Sahay P, et al.: Clinical spectrum of pseudoexfoliation syndrome-An electronic records audit. PLoS One. 2017;12(10): e0185373.
 
21.
Puska PM: Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma: a prospective 10-year follow-up study. J Glaucoma. 2002; 11(6): 517–524.
 
22.
Łukasik U, Kosior-Jarecka E, Wróbel-Dudzińska D, et al.: Clinical Features of Pseudoexfoliative Glaucoma in Treated Polish Patients. Clin Ophthalmol. 2020; 14: 1373–1381.
 
23.
Shin DY, Park CK, Lee NY: Characteristic Differences between Normotensive and Hypertensive Pseudoexfoliative Glaucoma. J Clin Med. 2024; 13(4): 1078.
 
24.
Fu H, Chang X: Management outcomes and clinical features of combined exfoliation syndrome with angle closure glaucoma. Sci Rep. 2025; 15(1): 19799.
 
25.
Holló G, Katsanos A, Konstas AG: Management of exfoliative glaucoma: challenges and solutions. Clin Ophthalmol. 2015; 9: 907–919.
 
26.
Pose-Bazarra S, López-Valladares MJ, López-de-Ullibarri I, et al.: Surgical and laser interventions for pseudoexfoliation glaucoma systematic review of randomized controlled trials. Eye (Lond). 2021; 35(6): 1551–1561.
 
27.
Plateroti P, Plateroti AM, Abdolrahimzadeh S, et al.: Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma: A Review of the Literature with Updates on Surgical Management. J Ophthalmol. 2015; 370371.
 
28.
Sharkawi E, Lindegger DJ, Artes PH, et al.: Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up. Br J Ophthalmol. 2021; 105(7): 977–982.
 
29.
Damji KF, Konstas AG, Liebmann JM, et al.: Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a 2 year prospective study. Br J Ophthalmol. 2006; 90(8): 1014–1018.
 
30.
Palko JR, Qi O, Sheybani A: Corneal Alterations Associated with Pseudoexfoliation Syndrome and Glaucoma: A Literature Review. J Ophthalmic Vis Res. 2017; 12(3): 312–324.
 
31.
Sangal N, Chen TC: Cataract surgery in pseudoexfoliation syndrome. Semin Ophthalmol. 2014; 29(5–6): 403–408.
 
32.
Aviv U, Ben Ner D, Sharif N, et al.: Pseudoexfoliation: An Ocular Finding with Possible Systemic Implications. Isr Med Assoc J. 2017; 19(1): 49–54.
 
eISSN:1689-362X
ISSN:1505-2753
Journals System - logo
Scroll to top